University of Illinois
Chicago IL
MD - Medicine
1971
University of Wisconsin
Madison WI
BS - Liberal Arts
1967
YTHDFs as radiotherapy checkpoints in tumor immunity.
YTHDFs as radiotherapy checkpoints in tumor immunity. J Exp Med. 2025 Aug 04; 222(8).
PMID: 40471119
Radiation-induced amphiregulin drives tumour metastasis.
Radiation-induced amphiregulin drives tumour metastasis. Nature. 2025 May 14.
PMID: 40369065
Transforming malignant tumors into vulnerable phenotypes via nanoscale coordination polymer mediated cell senescence and photodynamic therapy.
Transforming malignant tumors into vulnerable phenotypes via nanoscale coordination polymer mediated cell senescence and photodynamic therapy. Biomaterials. 2025 Nov; 322:123355.
PMID: 40279766
Facts and hopes in radioimmunotherapy of oligometastatic disease.
Facts and hopes in radioimmunotherapy of oligometastatic disease. Clin Cancer Res. 2025 Apr 17.
PMID: 40243665
Designing live bacterial therapeutics for cancer.
Designing live bacterial therapeutics for cancer. Adv Drug Deliv Rev. 2025 Jun; 221:115579.
PMID: 40228606
No disease left behind.
No disease left behind. Oncotarget. 2025 Mar 13; 16:163-166.
PMID: 40079896
Proceedings of the National Cancer Institute Workshop on combining immunotherapy with radiotherapy: challenges and opportunities for clinical translation.
Proceedings of the National Cancer Institute Workshop on combining immunotherapy with radiotherapy: challenges and opportunities for clinical translation. Lancet Oncol. 2025 Mar; 26(3):e152-e170.
PMID: 40049206
Nanoparticle-Mediated Toll-Like Receptor Activation and Dual Immune Checkpoint Downregulation for Potent Cancer Immunotherapy.
Nanoparticle-Mediated Toll-Like Receptor Activation and Dual Immune Checkpoint Downregulation for Potent Cancer Immunotherapy. ACS Nano. 2025 03 11; 19(9):8852-8866.
PMID: 40009747
N6-methyladenosine reader YTHDF2 in cell state transition and antitumor immunity.
N6-methyladenosine reader YTHDF2 in cell state transition and antitumor immunity. RNA. 2025 Feb 19; 31(3):395-401.
PMID: 39719324
Metal-organic layer delivers 3-bromopyruvate to mitochondria for metabolic regulation and cancer radio-immunotherapy.
Metal-organic layer delivers 3-bromopyruvate to mitochondria for metabolic regulation and cancer radio-immunotherapy. Chem Sci. 2025 Mar 19; 16(12):5234-5240.
PMID: 39991561